Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Association of Either Left Ventricular Hypertrophy or Diastolic Dysfunction With 24-Hour Central and Peripheral Blood Pressure.

Blanch P, Armario P, Oliveras A, Fernández-Llama P, Vázquez S, Pareja J, Álvarez E, Calero F, Sierra C, de la Sierra A.

Am J Hypertens. 2018 Nov 13;31(12):1293-1299. doi: 10.1093/ajh/hpy123.

PMID:
30084975
2.

Urinary Proteome Analysis Identified Neprilysin and VCAM as Proteins Involved in Diabetic Nephropathy.

Guillén-Gómez E, Bardají-de-Quixano B, Ferrer S, Brotons C, Knepper MA, Carrascal M, Abian J, Mas JM, Calero F, Ballarín JA, Fernández-Llama P.

J Diabetes Res. 2018 Apr 29;2018:6165303. doi: 10.1155/2018/6165303. eCollection 2018.

3.

Central blood pressure variability is increased in hypertensive patients with target organ damage.

de la Sierra A, Pareja J, Yun S, Acosta E, Aiello F, Oliveras A, Vázquez S, Armario P, Blanch P, Sierra C, Calero F, Fernández-Llama P.

J Clin Hypertens (Greenwich). 2018 Feb;20(2):266-272. doi: 10.1111/jch.13172. Epub 2018 Jan 25.

4.

[How does salt intake influence blood pressure? Associated aetiopathogenic mechanisms].

Fernández-Llama P, Calero F.

Hipertens Riesgo Vasc. 2017 Dec 15. pii: S1889-1837(17)30105-8. doi: 10.1016/j.hipert.2017.11.005. [Epub ahead of print] Spanish.

PMID:
29254634
5.

Cuff-Based Oscillometric Central and Brachial Blood Pressures Obtained Through ABPM are Similarly Associated with Renal Organ Damage in Arterial Hypertension.

Fernández-Llama P, Pareja J, Yun S, Vázquez S, Oliveras A, Armario P, Blanch P, Calero F, Sierra C, de la Sierra A.

Kidney Blood Press Res. 2017;42(6):1068-1077. doi: 10.1159/000485595. Epub 2017 Dec 4.

6.

Reply.

de la Sierra A, Oliveras A, Armario P, Fernández-Llama P.

J Hypertens. 2017 Nov;35(11):2324-2325. doi: 10.1097/HJH.0000000000001522. No abstract available.

PMID:
28953592
7.

Twenty-four-hour central blood pressure is not better associated with hypertensive target organ damage than 24-h peripheral blood pressure.

de la Sierra A, Pareja J, Fernández-Llama P, Armario P, Yun S, Acosta E, Calero F, Vázquez S, Blanch P, Sierra C, Oliveras A.

J Hypertens. 2017 Oct;35(10):2000-2005. doi: 10.1097/HJH.0000000000001431.

PMID:
28594710
8.

Cystatin C estimated glomerular filtration rate to assess renal function in early stages of autosomal dominant polycystic kidney disease.

Sans L, Radosevic A, Quintian C, Montañés R, Gràcia S, Vilaplana C, Mojal S, Ballarin JA, Fernández-Llama P, Torra R, Pascual J.

PLoS One. 2017 Mar 27;12(3):e0174583. doi: 10.1371/journal.pone.0174583. eCollection 2017.

9.

Renal volume and cardiovascular risk assessment in normotensive autosomal dominant polycystic kidney disease patients.

Sans L, Pascual J, Radosevic A, Quintian C, Ble M, Molina L, Mojal S, Ballarin JA, Torra R, Fernández-Llama P.

Medicine (Baltimore). 2016 Dec;95(49):e5595.

10.

[Hyperuricemia and cardiovascular risk: myth or fact?].

Fernández-Llama P, Calero F.

Hipertens Riesgo Vasc. 2015 Oct-Dec;32(4):131-2. doi: 10.1016/j.hipert.2015.09.004. Spanish. No abstract available.

PMID:
26486460
11.

Renal sodium transporters are increased in urinary exosomes of cyclosporine-treated kidney transplant patients.

Esteva-Font C, Guillén-Gómez E, Diaz JM, Guirado L, Facundo C, Ars E, Ballarin JA, Fernández-Llama P.

Am J Nephrol. 2014;39(6):528-35. doi: 10.1159/000362905. Epub 2014 Jun 12.

PMID:
24942911
12.

Hypertension in autosomal-dominant polycystic kidney disease (ADPKD).

Sans-Atxer L, Torra R, Fernández-Llama P.

Clin Kidney J. 2013 Oct;6(5):457-63. doi: 10.1093/ckj/sft031. Epub 2013 Apr 24. Review.

13.

Recombinant PTH associated with hypercalcaemia and renal failure.

Ayasreh N, Fernandez-Llama P, Lloret MJ, Da Silva I, Ballarín J, Bover J.

Clin Kidney J. 2013 Feb;6(1):93-95. Epub 2012 Nov 15. No abstract available.

14.

Molecular biology of water and salt regulation in the kidney.

Esteva-Font C, Ballarin J, Fernández-Llama P.

Cell Mol Life Sci. 2012 Mar;69(5):683-95. doi: 10.1007/s00018-011-0858-4. Epub 2011 Oct 14. Review.

PMID:
21997386
15.

[Relationship between renal size and blood pressure profile in patients with autosomal dominant polycystic kidney disease without renal failure].

Sans Atxer L, Roca-Cusachs A, Torra R, Calero F, Arias P, Ballarin J, Fernández-Llama P.

Nefrologia. 2010;30(5):567-72. doi: 10.3265/Nefrologia.pre2010.May.10418. Spanish.

16.

Recommendations for biomarker identification and qualification in clinical proteomics.

Mischak H, Allmaier G, Apweiler R, Attwood T, Baumann M, Benigni A, Bennett SE, Bischoff R, Bongcam-Rudloff E, Capasso G, Coon JJ, D'Haese P, Dominiczak AF, Dakna M, Dihazi H, Ehrich JH, Fernandez-Llama P, Fliser D, Frokiaer J, Garin J, Girolami M, Hancock WS, Haubitz M, Hochstrasser D, Holman RR, Ioannidis JP, Jankowski J, Julian BA, Klein JB, Kolch W, Luider T, Massy Z, Mattes WB, Molina F, Monsarrat B, Novak J, Peter K, Rossing P, Sánchez-Carbayo M, Schanstra JP, Semmes OJ, Spasovski G, Theodorescu D, Thongboonkerd V, Vanholder R, Veenstra TD, Weissinger E, Yamamoto T, Vlahou A.

Sci Transl Med. 2010 Aug 25;2(46):46ps42. doi: 10.1126/scitranslmed.3001249.

PMID:
20739680
17.

Tamm-Horsfall protein and urinary exosome isolation.

Fernández-Llama P, Khositseth S, Gonzales PA, Star RA, Pisitkun T, Knepper MA.

Kidney Int. 2010 Apr;77(8):736-42. doi: 10.1038/ki.2009.550. Epub 2010 Feb 3.

18.

Are sodium transporters in urinary exosomes reliable markers of tubular sodium reabsorption in hypertensive patients?

Esteva-Font C, Wang X, Ars E, Guillén-Gómez E, Sans L, González Saavedra I, Torres F, Torra R, Masilamani S, Ballarín JA, Fernández-Llama P.

Nephron Physiol. 2010;114(3):p25-34. doi: 10.1159/000274468. Epub 2010 Jan 12.

19.

Nephrin mutations cause childhood- and adult-onset focal segmental glomerulosclerosis.

Santín S, García-Maset R, Ruíz P, Giménez I, Zamora I, Peña A, Madrid A, Camacho JA, Fraga G, Sánchez-Moreno A, Cobo MA, Bernis C, Ortiz A, de Pablos AL, Pintos G, Justa ML, Hidalgo-Barquero E, Fernández-Llama P, Ballarín J, Ars E, Torra R; FSGS Spanish Study Group.

Kidney Int. 2009 Dec;76(12):1268-76. doi: 10.1038/ki.2009.381. Epub 2009 Oct 7.

20.

TRPC6 mutational analysis in a large cohort of patients with focal segmental glomerulosclerosis.

Santín S, Ars E, Rossetti S, Salido E, Silva I, García-Maset R, Giménez I, Ruíz P, Mendizábal S, Luciano Nieto J, Peña A, Camacho JA, Fraga G, Cobo MA, Bernis C, Ortiz A, de Pablos AL, Sánchez-Moreno A, Pintos G, Mirapeix E, Fernández-Llama P, Ballarín J, Torra R; FSGS Study Group, Zamora I, López-Hellin J, Madrid A, Ventura C, Vilalta R, Espinosa L, García C, Melgosa M, Navarro M, Giménez A, Cots JV, Alexandra S, Caramelo C, Egido J, San José MD, de la Cerda F, Sala P, Raspall F, Vila A, Daza AM, Vázquez M, Ecija JL, Espinosa M, Justa ML, Poveda R, Aparicio C, Rosell J, Muley R, Montenegro J, González D, Hidalgo E, de Frutos DB, Trillo E, Gracia S, de los Ríos FJ.

Nephrol Dial Transplant. 2009 Oct;24(10):3089-96. doi: 10.1093/ndt/gfp229. Epub 2009 May 20.

PMID:
19458060
21.

Preservation of renal function in a patient with Fabry nephropathy on enzyme replacement therapy.

Torra R, Algaba F, Ars E, Santin S, Fernández-Llama P, Ballarin J.

Clin Nephrol. 2008 Jun;69(6):445-9.

PMID:
18538121
22.

Diagnostic procedures and rationale for specific therapies in chronic kidney disease-mineral and bone disorder.

Bover J, Canal C, Marco H, Fernandez-Llama P, Bosch RJ, Ballarín J.

Contrib Nephrol. 2008;161:222-33. doi: 10.1159/000130690. Review.

PMID:
18451681
23.

Is albuminuria a marker of arterial remodeling?

Fernández-Llama P, Bover J.

J Hypertens. 2008 Apr;26(4):633-5. doi: 10.1097/HJH.0b013e3282f857f8. No abstract available.

PMID:
18327068
24.

Prevalence of cysts in seminal tract and abnormal semen parameters in patients with autosomal dominant polycystic kidney disease.

Torra R, Sarquella J, Calabia J, Martí J, Ars E, Fernández-Llama P, Ballarin J.

Clin J Am Soc Nephrol. 2008 May;3(3):790-3. doi: 10.2215/CJN.05311107. Epub 2008 Mar 5.

25.

[Albuminuria: beyond the kidney].

Bover J, Fernández-Llama P, Montañés R, Calero F.

Med Clin (Barc). 2008 Jan 19;130(1):20-3. Review. Spanish. No abstract available.

PMID:
18221642
26.

[Sodium transporters and aquaporins: future renal biomarkers?].

Esteva-Font C, Torra Balcells R, Fernández-Llama P.

Med Clin (Barc). 2007 Sep 29;129(11):433-7. Review. Spanish.

PMID:
17927939
27.

Genetic testing for X-linked Alport syndrome by direct sequencing of COL4A5 cDNA from hair root RNA samples.

Tazón-Vega B, Ars E, Burset M, Santín S, Ruíz P, Fernández-Llama P, Ballarín J, Torra R.

Am J Kidney Dis. 2007 Aug;50(2):257.e1-14.

PMID:
17660027
28.

Ciclosporin-induced hypertension is associated with increased sodium transporter of the loop of Henle (NKCC2).

Esteva-Font C, Ars E, Guillen-Gomez E, Campistol JM, Sanz L, Jiménez W, Knepper MA, Torres F, Torra R, Ballarín JA, Fernández-Llama P.

Nephrol Dial Transplant. 2007 Oct;22(10):2810-6. Epub 2007 Jun 25.

PMID:
17595192
29.

Study of candidate genes affecting the progression of renal disease in autosomal dominant polycystic kidney disease type 1.

Tazón-Vega B, Vilardell M, Pérez-Oller L, Ars E, Ruiz P, Devuyst O, Lens X, Fernández-Llama P, Ballarín J, Torra R.

Nephrol Dial Transplant. 2007 Jun;22(6):1567-77. Epub 2007 Feb 15.

PMID:
17303584
30.

Aquaporin-1 and aquaporin-2 urinary excretion in cirrhosis: Relationship with ascites and hepatorenal syndrome.

Esteva-Font C, Baccaro ME, Fernández-Llama P, Sans L, Guevara M, Ars E, Jiménez W, Arroyo V, Ballarín JA, Ginès P.

Hepatology. 2006 Dec;44(6):1555-63.

PMID:
17133493
31.

Ascites from cirrhotic patients induces angiogenesis through the phosphoinositide 3-kinase/Akt signaling pathway.

Morales-Ruiz M, Tugues S, Cejudo-Martín P, Ros J, Melgar-Lesmes P, Fernández-Llama P, Arroyo V, Rodés J, Jiménez W.

J Hepatol. 2005 Jul;43(1):85-91. Epub 2005 Apr 12.

PMID:
15890430
32.

Sodium retention in cirrhotic rats is associated with increased renal abundance of sodium transporter proteins.

Fernández-Llama P, Ageloff S, Fernández-Varo G, Ros J, Wang X, Garra N, Esteva-Font C, Ballarin J, Barcelo P, Arroyo V, Stokes JB, Knepper MA, Jiménez W.

Kidney Int. 2005 Feb;67(2):622-30.

33.

[Molecular bases for water/salt retention in experimental liver cirrhosis: aquaporins and renal sodium transporters].

Fernández-Llama P.

Nefrologia. 2002;22 Suppl 5:29-33. Review. Spanish. No abstract available.

34.

[Aquaporins and renal water metabolism. Role in the physiopathology of water retention in cirrhosis].

Fernández-Llama P.

Gastroenterol Hepatol. 2001 Apr;24(4):205-9. Review. Spanish. No abstract available.

PMID:
11333660
35.

[Molecular physiology of the urinary concentration mechanism, role of renal aquaporins].

Fernández-Llama P.

Nefrologia. 2000 Nov-Dec;20(6):486-94. Review. Spanish. No abstract available.

36.

Detection of Na(+) transporter proteins in urine.

McKee JA, Kumar S, Ecelbarger CA, Fernández-Llama P, Terris J, Knepper MA.

J Am Soc Nephrol. 2000 Nov;11(11):2128-32.

37.

Long-term regulation of renal Na-dependent cotransporters and ENaC: response to altered acid-base intake.

Kim GH, Martin SW, Fernández-Llama P, Masilamani S, Packer RK, Knepper MA.

Am J Physiol Renal Physiol. 2000 Sep;279(3):F459-67.

38.

Dysregulation of renal aquaporins and Na-Cl cotransporter in CCl4-induced cirrhosis.

Fernández-Llama P, Jimenez W, Bosch-Marcé M, Arroyo V, Nielsen S, Knepper MA.

Kidney Int. 2000 Jul;58(1):216-28.

39.

Reduced abundance of aquaporins in rats with bilateral ischemia-induced acute renal failure: prevention by alpha-MSH.

Kwon TH, Frøkiaer J, Fernández-Llama P, Knepper MA, Nielsen S.

Am J Physiol. 1999 Sep;277(3):F413-27. doi: 10.1152/ajprenal.1999.277.3.F413.

PMID:
10484525
40.

Renal expression of aquaporins in liver cirrhosis induced by chronic common bile duct ligation in rats.

Fernández-Llama P, Turner R, Dibona G, Knepper MA.

J Am Soc Nephrol. 1999 Sep;10(9):1950-7.

41.

Decreased abundance of collecting duct aquaporins in post-ischemic renal failure in rats.

Fernández-Llama P, Andrews P, Turner R, Saggi S, Dimari J, Kwon TH, Nielsen S, Safirstein R, Knepper MA.

J Am Soc Nephrol. 1999 Aug;10(8):1658-68.

42.

Altered expression of Na transporters NHE-3, NaPi-II, Na-K-ATPase, BSC-1, and TSC in CRF rat kidneys.

Kwon TH, Frøkiaer J, Fernández-Llama P, Maunsbach AB, Knepper MA, Nielsen S.

Am J Physiol. 1999 Aug;277(2):F257-70. doi: 10.1152/ajprenal.1999.277.2.F257.

PMID:
10444581
43.

Cyclooxygenase inhibitors increase Na-K-2Cl cotransporter abundance in thick ascending limb of Henle's loop.

Fernández-Llama P, Ecelbarger CA, Ware JA, Andrews P, Lee AJ, Turner R, Nielsen S, Knepper MA.

Am J Physiol. 1999 Aug;277(2):F219-26. doi: 10.1152/ajprenal.1999.277.2.F219.

PMID:
10444576
44.

[Genetic polymorphisms of the renin-angiotensin system and essential hypertension].

Fernández-Llama P, Poch E, Oriola J, Botey A, de la Sierra A, Revert L, Rivera F, Darnell A.

Med Clin (Barc). 1999 May 1;112(15):561-4. Review. Spanish.

PMID:
10365380
45.

Regulation of thick ascending limb transport by vasopressin.

Knepper MA, Kim GH, Fernández-Llama P, Ecelbarger CA.

J Am Soc Nephrol. 1999 Mar;10(3):628-34. Review. No abstract available.

46.

Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution.

Bladé J, Fernández-Llama P, Bosch F, Montolíu J, Lens XM, Montoto S, Cases A, Darnell A, Rozman C, Montserrat E.

Arch Intern Med. 1998 Sep 28;158(17):1889-93.

PMID:
9759684
47.

Concentrating defect in experimental nephrotic syndrone: altered expression of aquaporins and thick ascending limb Na+ transporters.

Fernández-Llama P, Andrews P, Ecelbarger CA, Nielsen S, Knepper M.

Kidney Int. 1998 Jul;54(1):170-9.

48.

Angiotensinogen gene M235T and T174M polymorphisms in essential hypertension: relation with target organ damage.

Fernández-Llama P, Poch E, Oriola J, Botey A, Rivera F, Revert L.

Am J Hypertens. 1998 Apr;11(4 Pt 1):439-44.

PMID:
9607382
49.

Angiotensin converting enzyme gene I/D polymorphism in essential hypertension and nephroangiosclerosis.

Fernández-Llama P, Poch E, Oriola J, Botey A, Coll E, Darnell A, Rivera F, Revert L.

Kidney Int. 1998 Jun;53(6):1743-7.

50.

Impaired aquaporin and urea transporter expression in rats with adriamycin-induced nephrotic syndrome.

Fernández-Llama P, Andrews P, Nielsen S, Ecelbarger CA, Knepper MA.

Kidney Int. 1998 May;53(5):1244-53.

Supplemental Content

Loading ...
Support Center